Hydrogels comprising cell adhesive peptides and methods of use thereof
US-2024376438-A1 · Nov 14, 2024 · US
US9572909B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9572909-B2 |
| Application number | US-201013394415-A |
| Country | US |
| Kind code | B2 |
| Filing date | Sep 14, 2010 |
| Priority date | Sep 14, 2009 |
| Publication date | Feb 21, 2017 |
| Grant date | Feb 21, 2017 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Nerve guides which are formed from three dimensional (3D) arrays of highly aligned electrospun fibers are provided. The electrospun fibers are oriented parallel to the long axis of the guide, and gaps and elongated spaces between the stacked fiber arrays provide channels for directed axonal growth. In some embodiments, the nerve guides also comprise high precision gradients of beneficial substances such as growth factors, which aid in nerve regeneration and growth along the guide.
Opening claim text (preview).
We claim: 1. A nerve guide, comprising a plurality of electrospun fibers which are seamlessly aligned parallel to a long axis of said nerve guide; at least one carrier thread comprising one or more therapeutic substances in a step gradient; and a plurality of open channels aligned parallel to said long axis of said nerve guide, wherein said at least one carrier thread is different from said plurality of electrospun fibers; wherein said at least one carrier thread comprises a plurality of segments, wherein each segment comprises the one or more therapeutic substances with a concentration that differs from the concentrations of said one or more therapeutic substances in adjacent segments such that a step gradient of concentration is formed. 2. The nerve guide of claim 1 , wherein said one or more therapeutic substances includes at least one growth factor. 3. The nerve guide of claim 1 , further comprising an outer sheath. 4. The nerve guide of claim 1 , wherein the total length of said at least one carrier thread is from 5 mm to 125 mm. 5. The nerve guide of claim 4 , wherein a length of any one of said plurality of segments is from 1 to 10 mm. 6. The nerve guide of claim 1 , wherein said at least one carrier thread further comprises microbeads present in at least one of the plurality of segments, said microbeads containing an agent of interest. 7. The nerve guide of claim 1 , wherein the step gradient is oriented at a non-zero angle to said long axis. 8. The nerve guide of claim 1 , wherein the step gradient is oriented at right angles to said long axis. 9. The nerve guide of claim 1 , wherein said gradient has a higher concentration in a middle segment of the at least one carrier thread as compared to other segments of said at least one carrier thread. 10. The nerve guide of claim 1 , wherein said at least one carrier thread comprises a plasticizing agent. 11. The nerve guide of claim 1 , wherein said at least one carrier thread comprises alginate.
of nerves · CPC title
for nerve reconstruction · CPC title
Prostheses implantable into the body · CPC title
obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds · CPC title
Polyesters derived from hydroxycarboxylic acids, e.g. lactones (C08L67/06 takes precedence) · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.